UNSPSC 51151629: Cycrimine

This classification denotes an antiparkinsonian agent and antimuscarinic agent with the molecular formula C19H29NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 543567RFQQ, chemically known as 1-piperidinepropanol, .alpha.-cyclopentyl-.alpha.-phenyl-, hydrochloride but generally known as cycrimine, which bears US NIH Compound Identifier 2911. European Medicines Agency schedules Cycrimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06867MIG.

UNSPSC 51151629 Cycrimine, a Commodity code, shows minimal relevant recent state and local activity. The Seminole County, Florida IFB60459723LAS, posted June 30, 2026, with a July 26, 2023 response date, solicits Naloxone and Safe Drug Deactivation Systems—products unrelated to Cycrimine's pharmaceutical scope. The Texas Health and Human Services Commission RFI HHS0017013, posted April 3, 2026, addresses direct-to-manufacturer prescription fulfillment and pharmacy benefit management strategies, which does not align with the specific drug classification this code nominally represents. Neither opportunity demonstrates procurement demand for Cycrimine itself under this code.

The code shows no documented state or local opportunities actively seeking Cycrimine as a line item or contract deliverable in the recent posting record. Without evidence of current solicitations, geographic concentration, or repeat issuing bodies procuring under this code, business development professionals should monitor future postings rather than pursue opportunities at this time. The mismatch between the code's nominal scope and the pharmaceutical-access and drug-safety initiatives currently tagged under it suggests either misclassification in state systems or limited use of this specific commodity code in state and local procurement.